Table 4

ORs and 95% CIs for plasma carotinoids, retinol and, tocopherols in 65 prostate cancer cases and 132 controls by quartile of plasma concentrations of controls

No. of casesNo. of controlsORa (adjusted)95% CIPORb (adjusted)95% CIP
Lycopene
 028331.000.00571.000.0052
 121330.670.25–1.760.640.23–1.75
 212330.260.09–0.780.290.09–0.90
 34330.240.06–0.900.170.04–0.78
 Continuousc651320.700.52–0.940.01650.670.49–0.920.0127
Zeaxanthin
 023331.000.00061.000.0028
 123330.810.29–2.320.970.31–3.07
 211330.180.06–0.570.180.05–0.64
 38330.180.05–0.610.220.06–0.83
 Continuousc651320.160.05–0.520.00200.200.06–0.650.0074
α-Carotene
 014331.000.06201.000.1617
 120330.620.20–1.890.570.18–1.80
 220330.760.26–2.260.940.29–3.04
 311330.240.07–0.860.260.07–1.05
 Continuousc651321.090.84–1.410.52761.050.77–1.440.7388
β-Carotene
 015331.000.22991.000.4541
 16330.220.06–0.810.230.60–0.88
 223330.650.23–1.900.700.23–2.16
 321330.360.12–1.110.430.13–1.49
 Continuousc651321.020.93–1.120.61121.040.94–1.160.4577
Lutein
 023331.000.00121.000.0064
 120330.650.22–1.930.960.29–3.14
 29330.180.06–0.580.170.05–0.59
 313330.210.07–0.640.300.09–1.03
 Continuousc651320.600.40–0.910.01490.650.43–0.970.0330
β-Cryptoxanthin
 017331.000.01871.000.0666
 121331.450.51–4.171.660.51–5.37
 219330.650.23–1.830.820.25–2.65
 38330.230.07–0.840.310.08–1.24
 Continuousc651320.420.22–0.790.00730.440.23–0.850.0153
Retinol
 010331.000.06671.000.1318
 126331.110.35–3.461.100.35–3.49
 226331.010.33–3.111.100.35–3.42
 33330.180.04–0.910.190.03–1.00
 Continuousc651320.930.87–0.990.03240.940.88–1.010.0743
α-Tocopherol
 05331.000.05321.000.1162
 127334.271.09–16.76.671.47–30.3
 221331.500.38–5.952.240.51–9.94
 312330.700.17–2.871.020.23–4.62
 Continuousc651320.9950.991–0.9990.01021.000.99–1.000.0208
γ-Tocopherol
 026331.000.39051.000.4136
 115331.040.35–3.051.230.40–3.78
 212330.850.29–2.460.810.26–2.49
 312330.650.24–1.780.660.22–1.97
 Continuousc651320.990.97–1.010.20770.990.97–1.010.2696
  • a ORs were adjusted for age only.

  • b ORs were adjusted for age, race, years of education, family history of prostate cancer, pack-years of smoking, alcohol consumption, and daily caloric intake.

  • c Continuous variable with 10 units of increment.